Placebo for Product 0405

DRUG2 trials

Sponsors

Fougera Pharmaceuticals Inc.

Conditions

Atopic Dermatitis

Phase 3

Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

WithdrawnNCT02176551

Fougera Pharmaceuticals Inc.Atopic Dermatitis

Start: 2012-06-30End: 2013-05-31Updated: 2014-06-27

Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

WithdrawnNCT02176538

Fougera Pharmaceuticals Inc.Atopic Dermatitis

Start: 2012-06-30End: 2013-05-31Updated: 2014-06-27